An emergency kit for nosebleed in children

Abstract

This utility model discloses an emergency kit for children's nosebleeds, comprising: a nasal hemostatic agent, cotton swabs, erythromycin ointment, and a packaging box. The nasal hemostatic agent includes a reservoir stick, a sponge strip, a push rod, and a sealing strip. The reservoir stick includes a base plate, side walls, and a top sealing film. The sponge strip is disposed outside the reservoir stick, and its bottom is connected to the top sealing film. The push rod passes through the base plate, with a mesh support connected to one end of the push rod, which is disposed inside the reservoir stick. The other end of the push rod has a push handle disposed outside the reservoir stick. A sealing strip is provided on the base plate to prevent leakage between the base plate and the push rod. This utility model provides an emergency kit for children's nosebleeds that can simultaneously achieve hemostasis through medication and physical pressure, effectively addressing nosebleeds in children and preventing the residue of fibrous material. The operation is simple, and the kit is easy to use. It can reduce the rate of crust formation, inhibit inflammatory reactions, and help maintain good moisture in the nasal mucosa.

Description

Technical Field

[0001] This utility model relates to the field of medical supplies technology, and more specifically, to an emergency kit for children with nosebleeds. Background Technology

[0002] Nosebleeds are a common nasal symptom in otolaryngology, usually caused by nasal diseases. Nosebleeds are frequently seen in otolaryngology departments; the condition develops rapidly and is considered an emergency. Clinical data shows that 30% of patients are children aged 3 to 8, and 56% are children aged 6 to 10. Recent clinical data indicates a higher probability of sudden nosebleeds in children, which is related to their weaker immune systems and higher incidence of upper respiratory tract infections. Upper respiratory tract infections are generally caused by pathogens invading the body and can cause significant damage to the respiratory system. Common clinical manifestations of upper respiratory tract infections include runny nose and nasal congestion, leading children to frequently pick their noses, thus causing sudden nosebleeds. The blood vessels in the nasal mucosa are easily affected by nose picking, resulting in bulging blood vessels. In this state, the nasal environment is more susceptible to invasion by Staphylococcus aureus, a pathogen that can induce nosebleeds.

[0003] For common nosebleeds in children, some parents often use incorrect methods to stop the bleeding, such as tilting the head back in the hope of stopping the bleeding, which may cause the child to suffocate. Other parents know how to use medication to stop the bleeding in addition to physical methods, but the traditional empirical method of stopping bleeding with medication usually involves wetting a medical cotton ball with medication and then having a family member manually insert it into the child's nostril. The problem with this method is that it is difficult to control the amount of medication and the number of cotton balls. Too little medication may not be effective, while too much may cause nasal discomfort, and cotton balls may also leave cotton wool residue in the nasal cavity.

[0004] Sudden nosebleeds are characterized by rapid development and high recurrence. Sudden bleeding or repeated episodes can cause a heavy psychological burden on patients and easily lead to panic among their families. Timely and correct treatment and effective care are key to accelerating recovery from nosebleeds and reducing complications. Therefore, it is necessary to design an emergency nasal bleeding product that can correctly deal with nosebleeds in children and is easy to use. Utility Model Content

[0005] To address the problems of existing technologies, this utility model provides an emergency kit for children with nosebleeds. The technical solution is as follows:

[0006] This utility model provides an emergency kit for children's nosebleeds, comprising: a nasal hemostatic agent, cotton swabs, erythromycin ointment, and a packaging box. The packaging box has grooves for placing the nasal hemostatic agent, cotton swabs, and erythromycin ointment. The nasal hemostatic agent includes a reservoir stick, a sponge strip, a push rod, and a sealing strip. The reservoir stick includes a base plate, side walls, and a top sealing film. The base plate and the top sealing film are both connected to the side walls. The sponge strip is located outside the reservoir stick, and its bottom is connected to the top sealing film, with the bottom of the sponge strip matching the top sealing film. The push rod passes through the base plate, and one end of the push rod is connected to a mesh support inside the reservoir stick. The mesh support has a needle for puncturing the top sealing film. The other end of the push rod has a push handle located outside the reservoir stick. The base plate has a sealing strip to prevent leakage between the base plate and the push rod.

[0007] Furthermore, the drug storage rod is cylindrical.

[0008] Furthermore, a handle is provided on the outer wall of the medicine storage rod.

[0009] Furthermore, the cotton swab includes a sponge ball, a baffle, and a paper stick, wherein the sponge ball is connected to the paper stick, and the baffle is disposed between the sponge ball and the paper stick.

[0010] Furthermore, the sponge strip is teardrop-shaped.

[0011] Furthermore, the packaging box is provided with a text labeling area for identifying text.

[0012] Furthermore, the packaging box is provided with a QR code identification area for identifying a QR code.

[0013] The beneficial effects of the technical solution provided by this utility model embodiment are:

[0014] This invention provides an emergency kit for children's nosebleeds, which can simultaneously provide hemostasis through medication and physical pressure, effectively and correctly addressing nosebleeds in children and preventing the residue of fibrous material. The operation is simple and convenient, allowing family members to operate independently, enabling timely treatment of nosebleeds, alleviating family anxiety, and reducing the psychological burden on the patient. It can reduce the rate of crust formation, inhibit inflammatory responses, and significantly lower the probability of Staphylococcus aureus infection in the nasal cavity, thus reducing the likelihood of subsequent nosebleeds. Applying erythromycin ointment to the nostrils can create a barrier against air, helping to maintain good humidity in the nasal mucosa and promoting its recovery. Attached Figure Description

[0015] To more clearly illustrate the technical solutions in the embodiments of this utility model, the drawings used in the description of the embodiments will be briefly introduced below. Obviously, the drawings described below are only some embodiments of this utility model. For those skilled in the art, other drawings can be obtained based on these drawings without creative effort.

[0016] Figure 1 This is a schematic diagram of an emergency kit for children with nosebleeds according to an embodiment of the present invention;

[0017] Figure 2 This is a cross-sectional view of the nasal hemostatic agent according to an embodiment of the present invention. Detailed Implementation

[0018] To make the objectives, technical solutions, and advantages of this utility model clearer, the embodiments of this utility model will be described in further detail below with reference to the accompanying drawings.

[0019] This utility model provides an emergency kit for children's nosebleeds, see [link to relevant documentation]. Figure 1-2 The product includes: a nasal hemostatic agent 1, cotton swabs 2, erythromycin ointment 3, and a packaging box 4. The packaging box 4 has grooves for placing the nasal hemostatic agent 1, a groove for placing the cotton swabs 2, and a groove for placing the erythromycin ointment 3. The nasal hemostatic agent 1 includes a reservoir stick 11, a sponge strip 12, a push rod 13, and a sealing strip 14. The reservoir stick 11 includes a base plate 111, a side wall 112, and a top sealing film 113. The base plate 111 and the top sealing film 113 are both connected to the side wall 112. The sponge strip 12 is disposed outside the reservoir stick 11. The bottom of the sponge strip 12 is connected to the top sealing film 113, and the bottom of the sponge strip 12 matches the top sealing film 113. The push rod 13 passes through the bottom plate 111, and one end of the push rod 13 is connected to a grid bracket 15. The grid bracket 15 is set inside the drug storage rod 11. The grid bracket 15 is provided with a sharp needle 151 for puncturing the top sealing film 113. The other end of the push rod 13 is provided with a push handle 131. The push handle 13 is set outside the drug storage rod 11. The bottom plate 111 is provided with a sealing strip 14 to prevent leakage between the bottom plate 111 and the push rod 13.

[0020] Specifically, the nasal hemostatic agent 1 is used to stop bleeding, the erythromycin ointment 3 is used to moisturize and inhibit Staphylococcus aureus, the cotton swab 2 is used to apply the erythromycin ointment 3 into the nostrils, and the packaging box 4 is provided with grooves for placing the nasal hemostatic agent 1, grooves for placing the cotton swab 2, and grooves for placing the erythromycin ointment 3; the nasal hemostatic agent 1 includes a drug reservoir 11, a sponge strip 12, a push rod 13, and a sealing strip 14; the drug reservoir 11 is used to store the drug solution, such as oxymetazoline solution, and the drug reservoir 11 includes... The storage rod 11 comprises a base plate 111, side walls 112, and a top sealing membrane 113. Both the base plate 111 and the top sealing membrane 113 are connected to the side walls 112. A push rod 13 passes through the base plate 111. A sealing strip 14 is installed at the point where the push rod 13 passes through the base plate 111 to prevent leakage through the gap between the push rod 13 and the base plate 111. The base plate 111, side walls 112, top sealing membrane 113, push rod 13, and sealing strip 14 together form a sealed space inside the storage rod 11 to prevent leakage. A sponge strip 12 is installed outside the storage rod 11. The bottom of the sponge strip 12 is connected to the top sealing membrane 113 by adhesive bonding, and the shape of the bottom of the sponge strip 12 matches the top sealing membrane 113. A grid support 15 is connected to one end of the push rod 13 inside the storage rod 11. Several sharp needles 151 are installed on the grid support 15. The sharp needles 151 are used to pierce the top sealing membrane 113, allowing the liquid medicine inside the storage rod 11 to enter the sponge strip 12. The sealing strip 14 is designed to prevent leakage from the gap between the push rod 13 and the base plate 111, and to prevent the push rod 13 from moving and causing the mesh support 15 to move and puncture the top sealing film 113. The sealing strip 14 has an end protrusion, which the user can pull to tear the sealing strip 14 open.

[0021] When using, place the sponge strip 12 downwards and the push handle 131 upwards, tear open the sealing strip 14, and use the push handle 131 to push the push rod 13 downwards. The mesh support 15 at the other end of the push rod 13 will move towards the top sealing film 113. The needles 151 on the mesh support 15 will puncture the top sealing film 113. Then pull back the push handle 131, and the medicine will enter the sponge strip 12 through the small holes on the top sealing film 113. Hold the medicine reservoir 11 and insert the sponge strip 12 into the bleeding nostril. Remove the medicine reservoir 11, leaving only the sponge strip 12 containing the medicine in the nostril. The sponge strip 12 containing the medicine will expand to a certain extent, producing a hemostatic effect and physical pressure at the site of nasal bleeding. Depending on the hemostasis, generally after about 5 minutes, pull the lower end of the sponge strip 12 and gently remove it. The sponge strip 12 is made of medical sponge to avoid leaving any fibrous material in the nasal cavity after removal. After stopping the nosebleed with nasal hemostatic agent 1, apply erythromycin ointment 3 to the inside of the nostrils using cotton swab 2. Erythromycin ointment 3 can inhibit bacteria such as Staphylococcus aureus, and at the same time, applying erythromycin ointment 3 can create a barrier against air, which is beneficial to maintaining good humidity of the nasal mucosa and promoting the recovery of the nasal mucosa. The sponge strip 12 and erythromycin ointment 3 work together to reduce the rate of crust formation, which is beneficial to the recovery of the patient's nasal mucosa and reduces the probability of subsequent nosebleeds. The operation steps are simple and convenient, which can promptly deal with nosebleeds in children, alleviate the anxiety of family members, and reduce the psychological burden on patients. Since the size of the nostrils of children of different ages varies, nasal hemostatic agent 1 is made according to different age groups, such as 3-6 years old and 6-12 years old, and is made in layers. The emergency kit can be divided into different models of emergency kits, or two different models of nasal hemostatic agent 1 can be placed in the same emergency kit. In this embodiment, the number of nasal hemostatic agent 1 and cotton swab 2 in the emergency kit is 3. In other embodiments, the number of nasal hemostatic agent 1 and cotton swab 2 in the emergency kit can be set to other numbers.

[0022] Furthermore, the medicine storage rod 11 is cylindrical.

[0023] Specifically, the drug storage rod 11 is cylindrical, but in other embodiments, other shapes may also be used.

[0024] Furthermore, a handle 114 is provided on the outer wall of the medicine storage rod 11.

[0025] Specifically, the handle 114 on the outer wall of the medicine storage rod 11 is located near the base plate 111. There are two handles 114. The handles 114 can be used in conjunction with the push handle 131, making it more convenient for the user to push the push rod.

[0026] Furthermore, the cotton swab 2 includes a sponge ball 21, a baffle 22, and a paper stick 23. The sponge ball 21 is connected to the paper stick 23, and the baffle 22 is disposed between the sponge ball 21 and the paper stick 23.

[0027] Specifically, the cotton swab 2 includes a sponge 21, a baffle 22, and a paper stick 23. The baffle 22 is used to block the nostrils to prevent the cotton swab 2 from going too deep into the nostrils and causing secondary damage to the nasal mucosa. After the nosebleed stops, erythromycin ointment 3 is applied to the sponge 21 and gently applied to the nostrils to moisturize.

[0028] Furthermore, the sponge strip 12 is in the shape of a water droplet.

[0029] Specifically, the sponge strip 12 is in the shape of a teardrop or other shapes suitable for the structure of the nostrils.

[0030] Furthermore, the packaging box 4 is provided with a text labeling area 41 for identifying text.

[0031] Specifically, the text label area 41 can indicate usage steps and precautions, so that users can more clearly understand and use the items in the emergency kit.

[0032] Furthermore, the packaging box 4 is provided with a QR code identification area 42 for identifying QR codes.

[0033] Specifically, the QR code identification area 42 is used to identify the QR code. Users can scan the QR code on the emergency box to learn about the usage steps and precautions of the emergency box.

[0034] The beneficial effects of the technical solution provided by this utility model embodiment are:

[0035] This utility model provides an emergency kit for children's nosebleeds, which can simultaneously stop bleeding with medication and physical pressure, effectively and correctly addressing nosebleeds in children and preventing the residue of nasal mucus. The operation is simple and convenient, allowing family members to operate independently, providing timely treatment for nosebleeds, alleviating family anxiety, and reducing the psychological burden on the patient. It can reduce the rate of crust formation, inhibit inflammatory responses, and significantly reduce the probability of Staphylococcus aureus infection in the nasal cavity, thus lowering the likelihood of subsequent nosebleeds. Applying erythromycin ointment to the nostrils can create a barrier against air, helping to maintain good humidity in the nasal mucosa and promoting its recovery.

[0036] The above are merely preferred embodiments of the present utility model and are not intended to limit the present utility model. Any modifications, equivalent substitutions, improvements, etc., made within the spirit and principles of the present utility model shall be included within the protection scope of the present utility model.

Claims

1. An emergency kit for nosebleed in children, characterized in that, include: The package includes a nasal hemostatic agent, cotton swabs, erythromycin ointment, and a packaging box. The packaging box has grooves for holding the nasal hemostatic agent, cotton swabs, and erythromycin ointment. The nasal hemostatic agent includes a reservoir, a sponge strip, a push rod, and a sealing strip. The reservoir includes a base plate, side walls, and a top sealing film. The base plate and the top sealing film are connected to the side walls. The sponge strip is located outside the reservoir, and its bottom is connected to and matches the top sealing film. The push rod passes through the base plate. One end of the push rod is connected to a mesh support inside the reservoir. The mesh support has a needle for puncturing the top sealing film. The other end of the push rod has a handle located outside the reservoir. The base plate has a sealing strip to prevent leakage between the base plate and the push rod.

2. The emergency kit for nosebleed in children according to claim 1, characterized in that, The drug storage rod is cylindrical.

3. The emergency kit for nosebleed in children according to claim 1, characterized in that, A handle is provided on the outer wall of the medicine storage rod.

4. The emergency kit for nosebleed in children according to claim 1, characterized in that, The cotton swab includes a sponge ball, a baffle, and a paper stick. The sponge ball is connected to the paper stick, and the baffle is disposed between the sponge ball and the paper stick.

5. The emergency kit for nosebleed in children according to claim 1, characterized in that, The sponge strip is teardrop-shaped.

6. The emergency kit for nosebleed in children according to claim 1, characterized in that, The packaging box has a text label area for identifying text.

7. The emergency kit for nosebleed in children according to claim 1, characterized in that, The packaging box has a QR code label area for identifying the QR code.

Images